InvestorsHub Logo
Followers 2
Posts 160
Boards Moderated 0
Alias Born 01/28/2014

Re: None

Thursday, 02/13/2014 11:49:16 AM

Thursday, February 13, 2014 11:49:16 AM

Post# of 140474
Regarding an earlier comment about ISRG and not being able to purchase Titan because of Anti-Trust Issues, I don’t believe that is going to be an issue. It is not as of Titan is producing and generating any revenue etc.

They would simply purchase them because Titans technology is way better than ISRG’s and they would incorporate it into their own current models and release Titans developed product (assuming it is fully developed by that time) as another product.

They would have all Titans patents as well.

In my opinion there are lots of reasons for ISRG to want to purchase Titan as well as many others however we just have to let it play out.

J&J would be a great fit and hopefully Hargrove can do something there.

Take a look at Stryker as this is an natural and easy purchase for them as well.

Regarding this mornings trading activity, its fine. It seems as if many of the flippers have slowed down their selling or are out already. If you look at the bids and offers there are some shares for sale but not like a couple days ago:

V:TMD Depth by Price @10:51:07http://www.stockwatch.com/App_Themes/Stockwatch/Images/chart_close.jpg

Bid
Ask
Price
1.31
1.32
1.33
1.34
1.35
1.36
1.37
1.38
1.39
1.40
Size
25,533
1,400
39,220
3,700
3,200
2,900
10,400
131,100
70,100
109,800
Orders
6
3
10
2
2
1
3
5
4
6

IMHO This will all play out fine in the long run.

On a side note, Theralase Technologies (TLTFF, TLT) had some positive news this morning. Lab results demonstrated bacteria destruction in hypoxic environments, giving further credence to the past research already completed by the company. Currently they are in the pre-clinical phase with their patented PDCs, but are about to release the TLC-2000, their new patented cold laser technology.